AbCellera Biologics Inc (ABCL)
2.83
-0.12
(-4.07%)
USD |
NASDAQ |
Nov 26, 16:00
2.84
+0.01
(+0.35%)
After-Hours: 06:39
AbCellera Biologics Total Assets (Quarterly): 1.393B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.393B |
| June 30, 2024 | 1.412B |
| March 31, 2024 | 1.463B |
| December 31, 2023 | 1.488B |
| September 30, 2023 | 1.512B |
| June 30, 2023 | 1.537B |
| March 31, 2023 | 1.498B |
| December 31, 2022 | 1.541B |
| September 30, 2022 | 1.552B |
| Date | Value |
|---|---|
| June 30, 2022 | 1.594B |
| March 31, 2022 | 1.592B |
| December 31, 2021 | 1.319B |
| September 30, 2021 | 1.173B |
| June 30, 2021 | 1.152B |
| March 31, 2021 | 1.129B |
| December 31, 2020 | 1.006B |
| September 30, 2020 | 142.39M |
| December 31, 2019 | 23.49M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
23.49M
Minimum
Dec 2019
1.594B
Maximum
Jun 2022
1.251B
Average
1.438B
Median
Total Assets (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 549.36M |
| Edesa Biotech Inc | 5.228M |
| Lexaria Bioscience Corp | 10.02M |
| InMed Pharmaceuticals Inc | 10.47M |
| Xenon Pharmaceuticals Inc | 835.90M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 314.73M |
| Shareholders Equity (Quarterly) | 1.078B |
| Current Ratio | 9.336 |